Applied Therapeutics Earning Date (APLT)

USA |NASDAQ |USD

APLT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2022 Sep 2022 - - $-1.09
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2022 Sep 2022 - - $0.00

Applied Therapeutics's next earnings date is Thursday, Nov 10, 2022 for the fiscal quarter ending Sep 2022.

APLT Earnings Date & History Chart

APLT Earnings & Revenue Forecast

APLT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $-3.23 $-4.18 $-2.32
Dec 2023 6 $-2.76 $-4.45 $-1.54

APLT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 4 / 0 $-4.11 $-3.97 $-4.54
Dec 2023 4 / 0 $-3.60 $-3.38 $-3.77

APLT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $1.12M $0.00 $3.00M
Dec 2023 5 $12.08M $0.00 $58.00M

APLT Earnings Date & Revenue History

APLT Earnings History

|
Show More
Show More

APLT Revenue History

|
Show More
Show More

Applied Therapeutics Next Earnings Date & Report

APLT Next Earnings Date & Report Preview: Sep 2022 (FQ)

APLT's next earnings date is Thursday, Nov 10, 2022 for the fiscal quarter ending Sep 30, 2022.

Applied Therapeutics Previous Earnings Dates & Reports

APLT Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Applied Therapeutics's previous earnings date was Aug 10, 2022 for its fiscal quarter ended Jun 30, 2022.

APLT Previous Earnings Date & Report Recap: Dec 2021 (FY)

Applied Therapeutics's previous annual earnings date was Mar 10, 2022 for its fiscal year ended Dec 31, 2021.

APLT's earnings per share (EPS) was $-4.12, beating the consensus analysts forecast of $-4.38 by -5.94% , and higher than the previous year's EPS (Dec 2020) by -3.06%.

Revenues were $0.00.

The company reported a net income of $-105.58M.

Applied Therapeutics reported a free cash flow of $-90.73M for its fiscal year, compared to $-78.21M a year ago.

The company ended the fiscal year with $1.33M in total debt, a decrease of -52.60% compared to the previous year.